1. Almerie MQ, Gossedge G, Wright KE, Jayne DG. Photodynamic diagnosis for
detection of peritoneal carcinomatosis. The Journal of surgical research 2015; 195(1):
175-187.
2. Spiliotis J, Halkia E, de Bree E. Treatment of peritoneal surface malignancies with hyperthermic intraperitoneal chemotherapy-current perspectives. Current oncology (Toronto, Ont) 2016; 23(3): e266-275.
3. Rajeev R, Turaga KK. Hyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal Carcinomatosis. Cancer control : journal of the Moffitt Cancer Center 2016; 23(1): 36-46.
4. International Recommendations for the Management of Peritoneal Metastases.
Peritoneal Surface Oncology Group International.
http://www.psogi.com/psogi/international-recommendations-for-the-management-of-p eritoneal-metastases/. Published 2016. Accessed October 16, 2018.
5. The 10 Take Home Messages of PSOGI 2016. Peritoneal Surface Oncology Group International. http://www.psogi.com/psogi/highlights-from-psogi-2016/the-10/.
Published 2016. Accessed October 16, 2018.
6. Carr NJ, Cecil TD, Mohamed F, et al. A Consensus for Classification and Pathologic Reporting of Pseudomyxoma Peritonei and Associated Appendiceal Neoplasia: The Results of the Peritoneal Surface Oncology Group International (PSOGI) Modified Delphi Process. The American journal of surgical pathology 2016; 40(1): 14-26.
7. Choudry HA, Pai RK. Management of Mucinous Appendiceal Tumors. Annals of surgical oncology 2018; 25(8): 2135-2144.
8. Rizvi SA, Syed W, Shergill R. Approach to pseudomyxoma peritonei. World journal of gastrointestinal surgery 2018; 10(5): 49-56.
9. Vassos N, Piso P. Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options. Current treatment options in oncology 2018; 19(10): 49.
10. Schmoll HJ, Van Cutsem E, Stein A, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. a personalized approach to clinical decision making. Annals of oncology : official journal of the European Society for Medical Oncology 2012; 23(10): 2479-2516.
11. Van Cutsem E, Cervantes A, Nordlinger B, Arnold D. Metastatic colorectal cancer:
ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology 2014; 25 Suppl 3: iii1-9.
12. Van Cutsem E, Cervantes A, Adam R, et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 2016; 27(8):
醫療科技評估報告補充資料
1386-1422.
13. Yoshino T, Arnold D, Taniguchi H, et al. Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a
JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS. Annals of oncology : official journal of the European Society for Medical Oncology 2018; 29(1):
44-70.
14. Benson AB, Venook AP, AI-Hawary MM, et al. NCCN Clinical Practice Guidelines in Oncology: Colon Cancer, Version 3.
https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Published 2018.
Accessed October 16, 2018.
15. Garcia-Fadrique A, Mehta A, Mohamed F, Dayal S, Cecil T, Moran BJ. Clinical presentation, diagnosis, classification and management of peritoneal mesothelioma: a review. Journal of gastrointestinal oncology 2017; 8(5): 915-924.
16. Hubert J, Thiboutot E, Dubé P, Cloutier AS, Drolet P, Sideris L. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal
mesothelioma: Preliminary results and survival analysis. Surgical Oncology 2015;
24(1): 41-46.
17. Elias D, Goere D, Dumont F, et al. Role of hyperthermic intraoperative peritoneal chemotherapy in the management of peritoneal metastases. European journal of cancer (Oxford, England : 1990) 2014; 50(2): 332-340.
18. Kim J, Bhagwandin S, Labow DM. Malignant peritoneal mesothelioma: a review.
Annals of translational medicine 2017; 5(11): 236.
19. Network. NCC. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines® ). Gastric Cacner Version 2.2018－May 22, 2018. . National Comprehensive Cancer Network.
https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf. Published 2018.
Accessed October 25, 2018.
20. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 2017; 20(1): 1-19.
21. Excellence NIfHaC. Oesophago-gastric cancer: assessment and management in adults.
National Institute for Health and Care Excellence. National Institute for Health and Care Excellence.
https://www.nice.org.uk/guidance/ng83/resources/oesophagogastric-cancer-assessmen t-and-management-in-adults-pdf-1837693014469. Published 2018. Accessed October 25, 2018.
22. Smyth EC, Verheij M, Allum W, et al. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27(suppl 5):
v38-v49.
醫療科技評估報告補充資料
23. 臺北市立聯合醫院癌症防治研究發展中心癌症資訊網.
http://website.tpech.gov.tw/cancer/%E7%99%8C%E7%97%87%E9%A0%90%E9%9 8%B2%E8%88%87%E7%AF%A9%E6%AA%A2/%E5%8D%B5%E5%B7%A2%E 7%99%8C%E7%B0%A1%E4%BB%8B.html. Accessed Oct 08, 2018.
24. 國泰綜合醫院婦產科. 卵巢癌.
https://www.cgh.org.tw/tw/content/article/healthy/397.pdf. Accessed Oct 16, 2018.
25. Ovarian cancer.
https://www.nccn.org/patients/guidelines/ovarian/files/assets/common/downloads/files /ovarian.pdf. Accessed.
26. Bhatt A, Glehen O. The role of Cytoreductive Surgery and Hyperthermic
Intraperitoneal Chemotherapy (HIPEC) in Ovarian Cancer: A Review. Indian journal of surgical oncology 2016; 7(2): 188-197.
27. Bakrin N, Classe JM, Pomel C, Gouy S, Chene G, Glehen O. Hyperthermic
intraperitoneal chemotherapy (HIPEC) in ovarian cancer. Journal of visceral surgery 2014; 151(5): 347-353.
28. Glehen O, Mohamed F, Gilly FN. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal
chemohyperthermia. The Lancet Oncology 2004; 5(4): 219-228.
29. van Driel WJ, Koole SN, Sikorska K, et al. Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer. The New England journal of medicine 2018;
378(3): 230-240.
30. Mulier S, Claes JP, Dierieck V, et al. Survival benefit of adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the different time-points of treatment of ovarian cancer: review of evidence. Current pharmaceutical design 2012; 18(25):
3793-3803.
31. Cavaliere D, Cirocchi R, Coccolini F, et al. 1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer. Tumori 2017; 103(6): 525-536.
32. Canadian Agency for Drugs and Technologies in Health.
https://www.cadth.ca/search?keywords=HIPEC. Accessed Oct 08, 2018.
33. Medical Services Advisory Committee.
http://search.health.gov.au/s/search.html?query=Hyperthermic+Intraperitoneal+Chem otherapy&collection=health&profile=msac&Submit=&start_rank=1. Accessed Oct 08, 2018.
34. The National Institute for Health and Care Excellence. Cytoreduction surgery followed by hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis (IPG331).
https://www.nice.org.uk/search?q=Hyperthermic+Intraperitoneal+Chemotherapy.
Accessed Oct 08, 2018.
醫療科技評估報告補充資料
35. Public Health England. Clinical governance.
https://www.gov.uk/government/publications/newborn-hearing-screening-programme-nhsp-operational-guidance/4-clinical-governance. Accessed Oct 19, 2018.
36. Scottish Medicines Consortium.
https://www.scottishmedicines.org.uk/search/?keywords=Hyperthermic+Intraperitone al+Chemotherapy. Accessed Oct 23, 2018.
37. Healthcare Improvement Scotland.
http://www.healthcareimprovementscotland.org/system_pages/search.aspx?p=1&rpp=
10&f=2%3A0&q=Hyperthermic+Intraperitoneal+Chemotherapy. Accessed Oct 23, 2018.
38. National Health Service for Scotland.
https://nhsnss.org/search?q=Hyperthermic+Intraperitoneal+Chemotherapy. Accessed Oct 23, 2018.
39. McBride K, McFadden D, Osler T. Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a
systematic review and meta-analysis. The Journal of surgical research 2013; 183(1):
246-252.
40. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003; 21(20): 3737-3743.
41. Verwaal VJ, Bruin S, Boot H, van Slooten G, van Tinteren H. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Annals of surgical oncology 2008; 15(9): 2426-2432.
42. Quenet F, Elias D, Roca L, et al. Perioperative outcomes of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal carcinomatosis: PRODIGE 7 randomized trial. European journal of surgical oncology Conference: 36th congress of the european society of surgical oncology in partnership with the polish society of surgical oncology, ESSO 36 Poland 2016; 42(9): S107.
43. UNICANCER. Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer.
https://clinicaltrials.gov/ct2/show/NCT00769405?term=NCT00769405&rank=1.
Published 2016. Accessed October 24, 2018.
44. Quenet F, Elias D, Roca L, et al. A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC):
醫療科技評估報告補充資料
PRODIGE 7. American Society of Clinical Oncology.
https://meetinglibrary.asco.org/record/158740/abstract. Published 2018. Accessed October 28, 2018.
45. Jacobson A. 2018 ASCO Annual Meeting Highlights: Colorectal Cancer. The Oncologist.
http://theoncologist.alphamedpress.org/site/conference/asco/2018/prodige.xhtml.
Published 2018. Accessed October 28, 2018.
46. Huang CQ, Min Y, Wang SY, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival for peritoneal carcinomatosis from colorectal cancer: a systematic review and meta-analysis of current evidence.
Oncotarget 2017; 8(33): 55657-55683.
47. Helm JH, Miura JT, Glenn JA, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: a systematic review and meta-analysis. Annals of surgical oncology 2015; 22(5): 1686-1693.
48. Rudloff U, Langan RC, Mullinax JE, et al. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial. Journal of surgical oncology 2014; 110(3): 275-284.
49. Li Y, Zhou Y, Xie C, et al. Cytoreductive surgery plus hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis from gastric cancer. Chinese Journal of Clinical Oncology 2012; 39(22): 1734-1740.
50. Yang XJ, Huang CQ, Suo T, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal
carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Annals of surgical oncology 2011; 18(6): 1575-1581.
51. Desiderio J, Chao J, Melstrom L, et al. The 30-year experience-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. European journal of cancer (Oxford, England : 1990) 2017; 79: 1-14.
52. Huo YR, Richards A, Liauw W, Morris DL. Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015; 41(12): 1578-1589.
53. Hotouras A, Desai D, Bhan C, Murphy J, Lampe B, Sugarbaker PH. Heated
IntraPEritoneal Chemotherapy (HIPEC) for Patients With Recurrent Ovarian Cancer:
A Systematic Literature Review. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2016; 26(4):
661-670.
醫療科技評估報告補充資料
54. Spiliotis J, Halkia E, Lianos E, et al. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Annals of surgical oncology 2015; 22(5): 1570‐1575.
55. Li CY, Alexander HR, Jr. Peritoneal Metastases from Malignant Mesothelioma.
Surgical oncology clinics of North America 2018; 27(3): 539-549.
56. 56. Sugarbaker PH. Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2001; 27(3):
239-243.
57. NHMRC. How to use the evidence: assessment and application of scientific evidence.
Canberra: National Health and Medical Research Council : 2000.
https://pdfs.semanticscholar.org/2d7a/07f7cdc2788de42360199ba5f86b10965b0a.pdf.
Accessed Oct 19, 2018.
58. Oxford Centre for Evidence-Based Medicine 2011 Levels of Evidence.
https://www.cebm.net/wp-content/uploads/2014/06/CEBM-Levels-of-Evidence-2.1.pd f. Accessed Oct 22, 2018.
59. Razenberg LG, van Gestel YR, Creemers GJ, Verwaal VJ, Lemmens VE, de Hingh IH.
Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015;
41(4): 466-471.
60. Bakrin N, Bereder JM, Decullier E, et al. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2013; 39(12):
1435-1443.
61. Bonastre J, Chevalier J, Elias D, et al. Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer. Value in health : the journal of the International Society for
Pharmacoeconomics and Outcomes Research 2008; 11(3): 347-353.
62. Chua TC, Martin S, Saxena A, et al. Evaluation of the cost-effectiveness of
cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the st george hospital peritoneal surface malignancy program. Annals of Surgery 2010; 251(2): 323-329.
63. Hultman B, Lundkvist J, Glimelius B, Nygren P, Mahteme H. Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery
醫療科技評估報告補充資料
and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer. Acta oncologica (Stockholm, Sweden) 2012; 51(1): 112-121.
64. Lee ZJ, Chia SL, Tan G, Soo KC, Teo CCM. Cost Effectiveness of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Management of Colorectal Peritoneal Carcinomatosis. Annals of surgical oncology 2018; 25(8):
2340-2346.
65. Baratti D, Scivales A, Balestra MR, et al. Cost analysis of the combined procedure of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2010; 36(5):
463-469.
66. Bagnoli PF, Cananzi FC, Brocchi A, et al. Peritonectomy and hyperthermic
intraperitoneal chemotherapy: cost analysis and sustainability. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2015; 41(3): 386-391.
醫療科技評估報告補充資料
附錄
附錄一、「腹腔溫熱灌注管路組」建議給付規定
1. 須事前審查，提供 3 個月內之電腻斷層、核磁共振或正子掃描等影像檢查，確 認無腹膜以外轉移病灶。
2. 限有病理報告證明為下列疾病，可接受腫瘤減量手術後，同時施行腹腔內熱化 療：闌尾黏液癌(pseudomyxoma peritonei)、大腸直腸癌(colorectal cancer)、腹膜 間皮瘤(peritoneal mesothelioma)、胃癌(gastric cancer)、卵巢癌(ovarian cancer)。
3. 手術者須預期前述 5 項腫瘤接受減容手術前無腹膜外轉移，術中可完成適當的 減容手術者(即殘存腫瘤直徑小於 0.25 公分以下)。
4. 需記錄術中下列資料，包括該次手術腹腔轉移及切除器官之相關病理報告、腹 腔內溫度/時間記錄表、手術記錄及彩色相片。
5. 每次限使用腹腔溫熱灌注治療套組 1 組，灌注導管最多使用 4 條。
醫療科技評估報告補充資料
附錄二、療效評估文獻搜尋策略
1. 腹膜假黏液瘤
Cochrane Library
查詢日期 編號 關鍵字 篇數
2018/10/18 #1 MeSH descriptor: [Pseudomyxoma Peritonei] explode all trees 2
#2
"Pseudomyxoma peritonei" or "peritoneum pseudomyxoma" or
"peritoneal pseudomyxoma " 16
#3 #1 or #2 16
#4 MeSH descriptor: [Hyperthermia, Induced] explode all trees 1464
#5
HIPEC or "hyperthermic intraperitoneal chemotherapy" or "heated intraoperative intraperitoneal chemotherapy" or "intraperitoneal chemotherapy" or "intraoperative chemotherapy" or "intraperitoneal heated chemotherapy" or "hyperthermic intraperitoneal chemoperfusion"
"pseudomyxoma peritonei"[MeSH Terms] OR ("pseudomyxoma"[All Fields] AND "peritonei"[All Fields]) OR
"pseudomyxoma peritonei"[All Fields] OR (("peritoneum"[MeSH Terms] OR "peritoneum"[All Fields]) AND pseudomyxoma[All Fields])
1539
#2 "hyperthermia, induced"[MeSH Terms] 29266
#3
"hyperthermic intraperitoneal chemotherapy"[All Fields] OR
"heated intraoperative intraperitoneal chemotherapy"[All Fields]
OR "intraperitoneal chemotherapy"[All Fields] OR "intraoperative chemotherapy"[All Fields] OR "intraperitoneal heated chemotherapy"[All Fields] OR "hyperthermic intraperitoneal chemoperfusion"[All Fields]
3144
#4
"cytoreduction surgical procedures"[MeSH Terms] OR ("cytoreduction"[All Fields] AND "surgical"[All Fields] AND
"procedures"[All Fields]) OR "cytoreduction surgical procedures"[All Fields] OR ("cytoreductive"[All Fields] AND
"surgery"[All Fields]) OR "cytoreductive surgery"[All Fields] OR cytoreduction[All Fields]
7257
#5 (#2 OR #3) AND #4 2121
醫療科技評估報告補充資料
#6 #1 AND #5 351
#7 #6 AND (systematic[sb] OR Randomized Controlled Trial[ptyp]
OR Meta-Analysis[ptyp])
'pseudomyxoma peritonei'/exp OR 'pseudomyxoma peritonei' OR (('pseudomyxoma'/exp OR pseudomyxoma) AND peritonei) OR 'peritoneum pseudomyxoma'/exp OR 'peritoneum pseudomyxoma'
2231
#2
'hyperthermic intraperitoneal chemotherapy' OR 'heated intraoperative intraperitoneal chemotherapy' OR 'intraperitoneal chemotherapy' OR 'intraoperative chemotherapy' OR 'intraperitoneal heated chemotherapy' OR 'hyperthermic intraperitoneal chemoperfusion'
5001
#3 'cytoreductive surgery' OR cytoreduction 16934
#4 #1 AND #2 AND #3 544
#5
#4 AND ([cochrane review]/lim OR [systematic review]/lim OR [meta analysis]/lim OR [controlled clinical trial]/lim OR [randomized controlled trial]/lim)
16
2. 大腸直腸癌
Cochrane Library
查詢日期 編號 關鍵字 篇數
2018/10/18 #1 MeSH descriptor: [Colorectal Neoplasms] explode all trees 6876
#2 "colorectal cancer" or "colon cancer" 10534
#3 MeSH descriptor: [Peritoneal Neoplasms] explode all trees 274
#4
"peritoneal carcinomatosis" or "peritoneal carcinomatoses" or
"peritoneal metastasis" or "peritoneal metastases" 332
#5 (#1 or #2) and (#3 or #4) 109
#6 MeSH descriptor: [Hyperthermia, Induced] explode all trees 1464
#7
HIPEC or "hyperthermic intraperitoneal chemotherapy" or "heated intraoperative intraperitoneal chemotherapy" or "intraperitoneal chemotherapy" or "intraoperative chemotherapy" or "intraperitoneal heated chemotherapy" or "hyperthermic intraperitoneal chemoperfusion"
326
#8
MeSH descriptor: [Cytoreduction Surgical Procedures] explode all
trees 28
#9 "cytoreductive surgery" or "cytoreduction surgery" 662
醫療科技評估報告補充資料
#10 #5 and (#6 or #7) and (#8 or #9) 48
PubMed
查詢日期 編號 關鍵字 篇數
2018/10/18 #1 "colorectal neoplasms"[MeSH Terms] 184076
#2 "colorectal cancer"[All Fields] OR "colon cancer"[All Fields] 118439
#3 "peritoneal neoplasms"[MeSH Terms] 14724
#4
"peritoneal carcinomatosis"[All Fields] OR "peritoneal carcinomatoses"[All Fields] OR "peritoneal metastasis"[All Fields]
OR "peritoneal metastases"[All Fields]
5355
#5 (#1 OR #2) AND (#3 OR #4) 2147
#6 "hyperthermia, induced"[MeSH Terms] 29266
#7
"hyperthermic intraperitoneal chemotherapy"[All Fields] OR
"heated intraoperative intraperitoneal chemotherapy"[All Fields]
OR "intraperitoneal chemotherapy"[All Fields] OR "intraoperative chemotherapy"[All Fields] OR "intraperitoneal heated chemotherapy"[All Fields] OR "hyperthermic intraperitoneal chemoperfusion"[All Fields]
3144
#8
"cytoreduction surgical procedures"[MeSH Terms] OR ("cytoreduction"[All Fields] AND "surgical"[All Fields] AND
"procedures"[All Fields]) OR "cytoreduction surgical procedures"[All Fields] OR ("cytoreductive"[All Fields] AND
"surgery"[All Fields]) OR "cytoreductive surgery"[All Fields] OR cytoreduction[All Fields]
7257
#9 (#6 OR #7) AND #8 2121
#10 #5 AND #9 582
#11
#10 AND (Randomized Controlled Trial[ptyp] OR
Meta-Analysis[ptyp] OR systematic[sb]) 52 Embase
查詢日期 編號 關鍵字 篇數
2018/10/18 #1 'colorectal cancer' OR 'colon cancer' OR 'colorectal neoplasms' 237926
#2
'peritoneal carcinomatosis' OR 'peritoneal carcinomatoses' OR
'peritoneal metastasis' OR 'peritoneal metastases' 8010
#3
'hyperthermic intraperitoneal chemotherapy' OR 'heated intraoperative intraperitoneal chemotherapy' OR 'intraperitoneal chemotherapy' OR 'intraoperative chemotherapy' OR 'intraperitoneal heated chemotherapy' OR 'hyperthermic intraperitoneal chemoperfusion'
5001
#4 'cytoreductive surgery' OR cytoreduction 16934
醫療科技評估報告補充資料
#5 #1 AND #2 AND #3 AND #4 716
#6
#5 AND ([cochrane review]/lim OR [systematic review]/lim OR [meta analysis]/lim OR [controlled clinical trial]/lim OR [randomized controlled trial]/lim)
65
3. 胃癌
Cochrane Library
查詢日期 編號 關鍵字 篇數
2018/10/15 #1 MeSH descriptor: [Hyperthermia, Induced] explode all trees 1464
#2 Hyperthermic Intraperitoneal Chemotherapy 209
#3 heated intraoperative intraperitoneal chemotherapy 4
#4 #1 OR #2 OR #3 1642
#5 MeSH descriptor: [Stomach Neoplasms] explode all trees 2205
#6 gastric OR #5 20820
#7 #4 AND #6 82
PubMed
查詢日期 編號 關鍵字 篇數
2018/10/15 #1 Search "Hyperthermia, Induced"[Mesh] 29231
#2 Search "Stomach Neoplasms"[Mesh] 89601
#3 Search ("Hyperthermia, Induced"[Mesh]) AND "Stomach Neoplasms"[Mesh]
335
#4
Search ("Hyperthermia, Induced"[Mesh]) AND "Stomach Neoplasms"[Mesh] Filters: Randomized Controlled Trial;
Meta-Analysis; Systematic Reviews
40
#5
Search (Hyperthermic Intraperitoneal Chemotherapy) OR heated intraoperative intraperitoneal chemotherapy
36214
#6 Search gastric 380038
#7 Search (((Hyperthermic Intraperitoneal Chemotherapy) OR heated intraoperative intraperitoneal chemotherapy)) AND gastric
747
#8
Search (((Hyperthermic Intraperitoneal Chemotherapy) OR heated intraoperative intraperitoneal chemotherapy)) AND gastric Filters:
Publication date from 2018/01/01 to 2018/12/31
31
#9
Search ((("Hyperthermia, Induced"[Mesh]) AND "Stomach Neoplasms"[Mesh] AND ( ( Randomized Controlled Trial[ptyp]
OR Meta-Analysis[ptyp] OR systematic[sb] ) ))) OR (((((Hyperthermic Intraperitoneal Chemotherapy) OR heated intraoperative intraperitoneal chemotherapy)) AND gastric) AND
70
醫療科技評估報告補充資料
( "2018/01/01"[PDat] : "2018/12/31"[PDat] )) Embase
查詢日期 編號 關鍵字 篇數
2018/10/15
#1
'hyperthermic intraperitoneal chemotherapy'/exp OR 'hyperthermic intraperitoneal chemotherapy' OR 'heated intraoperative intraperitoneal chemotherapy'
2546
#2 'thermochemotherapy'/exp OR 'thermochemotherapy' 359
#3 #1 OR #2 2905
#4 'stomach cancer'/exp OR 'stomach cancer' 108241
#5
#3 AND #4 AND ([cochrane review]/lim OR [systematic review]/lim OR [meta analysis]/lim OR [randomized controlled trial]/lim) AND ([article]/lim OR [article in press]/lim OR
Hyperthermic Intraperitoneal Chemotherapy, peritoneal
mesothelioma 9
#2 Hyperthermic Intraperitoneal Chemotherapy, peritoneal
mesothelioma (2013 至 2018 年) 7
PubMed
查詢日期 編號 關鍵字 篇數
2018/10/8、
#1
(("hyperthermia, induced"[MeSH Terms] OR ("hyperthermia"[All Fields] AND "induced"[All Fields]) OR "induced hyperthermia"[All Fields] OR ("hyperthermic"[All Fields] AND
"intraperitoneal"[All Fields] AND "chemotherapy"[All Fields]) OR
"hyperthermic intraperitoneal chemotherapy"[All Fields]) AND ("hyperthermia, induced"[MeSH Terms] OR ("hyperthermia"[All Fields] AND "induced"[All Fields]) OR "induced hyperthermia"[All Fields] OR "hipec"[All Fields]) AND ("peritoneum"[MeSH Terms] OR "peritoneum"[All Fields] OR
"peritoneal"[All Fields]) AND ("mesothelioma"[MeSH Terms] OR
"mesothelioma"[All Fields])) AND ("humans"[MeSH Terms] AND English[lang])
184
2018/10/10
#2 (("hyperthermia, induced"[MeSH Terms] OR ("hyperthermia"[All Fields] AND "induced"[All Fields]) OR "induced
94
醫療科技評估報告補充資料
hyperthermia"[All Fields] OR ("hyperthermic"[All Fields] AND
"intraperitoneal"[All Fields] AND "chemotherapy"[All Fields]) OR
"hyperthermic intraperitoneal chemotherapy"[All Fields]) AND ("hyperthermia, induced"[MeSH Terms] OR ("hyperthermia"[All Fields] AND "induced"[All Fields]) OR "induced hyperthermia"[All Fields] OR "hipec"[All Fields]) AND ("peritoneum"[MeSH Terms] OR "peritoneum"[All Fields] OR
"peritoneal"[All Fields]) AND ("mesothelioma"[MeSH Terms] OR
"mesothelioma"[All Fields])) AND ("humans"[MeSH Terms] AND English[lang]) AND (("2013/01/01"[PDAT] : "2018/12/31"[PDAT]) AND "humans"[MeSH Terms] AND English[lang] AND cancer[sb])
Embase
查詢日期 編號 關鍵字 篇數
2018/10/11
#1
hyperthermic AND intraperitoneal AND chemotherapy, AND
peritoneal AND mesothelioma 449
#2
('peritoneal mesothelioma, hyperthermic intraperitoneal chemotherapy' OR (peritoneal AND mesothelioma, AND hyperthermic AND intraperitoneal AND ('chemotherapy'/exp OR chemotherapy))) AND [humans]/lim AND ([article]/lim OR [article in press]/lim) AND [2013-2018]/py AND [english]/lim
126
5. 卵巢癌
Cochrane Library
查詢日期 編號 關鍵字 篇數
2018/10/8 #1 Hyperthermic Intraperitoneal Chemotherapy, ovarian 70
#2
Hyperthermic Intraperitoneal Chemotherapy, ovarian (2013 至 2018)
("hyperthermia, induced"[MeSH Terms] OR ("hyperthermia"[All Fields] AND "induced"[All Fields]) OR "induced hyperthermia"[All Fields] OR ("hyperthermic"[All Fields] AND
"intraperitoneal"[All Fields] AND "chemotherapy"[All Fields]) OR
"hyperthermic intraperitoneal chemotherapy"[All Fields]) AND ("ovarian neoplasms"[MeSH Terms] OR ("ovarian"[All Fields]
AND "neoplasms"[All Fields]) OR "ovarian neoplasms"[All Fields]
OR ("ovarian"[All Fields] AND "cancer"[All Fields]) OR "ovarian
638
醫療科技評估報告補充資料
cancer"[All Fields]) 2018/1010
#2
("hyperthermia, induced"[MeSH Terms] OR ("hyperthermia"[All Fields] AND "induced"[All Fields]) OR "induced hyperthermia"[All Fields] OR ("hyperthermic"[All Fields] AND
"intraperitoneal"[All Fields] AND "chemotherapy"[All Fields]) OR
"hyperthermic intraperitoneal chemotherapy"[All Fields]) AND ("ovarian neoplasms"[MeSH Terms] OR ("ovarian"[All Fields]
AND "neoplasms"[All Fields]) OR "ovarian neoplasms"[All Fields]
OR ("ovarian"[All Fields] AND "cancer"[All Fields]) OR "ovarian cancer"[All Fields]) AND (("2013/01/01"[PDAT] :
"2018/12/31"[PDAT]) AND "humans"[MeSH Terms] AND English[lang] AND cancer[sb])
224
Embase
查詢日期 編號 關鍵字 篇數
2018/10/8
#1
hyperthermic intraperitoneal chemotherapy, ovarian cancer' OR (hyperthermic AND intraperitoneal AND chemotherapy, AND ovarian AND ('cancer'/exp OR cancer))
708
#2
hyperthermic AND intraperitoneal AND chemotherapy, AND ovarian AND ([article]/lim OR [article in press]/lim) AND [english]/lim AND [humans]/lim
285
#3 #2 AND 'clinical article'/de 104
#4 #2 AND 'clinical article'/de AND [2013-2018]/py 52
#5
hyperthermic AND intraperitoneal AND chemotherapy, AND ovarian AND ([article]/lim OR [article in press]/lim) AND ([cochrane review]/lim OR [systematic review]/lim OR [meta analysis]/lim)
4
醫療科技評估報告補充資料
附錄三、經濟評估文獻搜尋策略
資料庫 查詢日期 關鍵字 篇數 篩選後篇數
Pubmed 2018.03.19 #1 Peritoneal Carcinomatosis
#2 Hyperthermic Intraperitoneal Chemotherapy
#3 (((cost-effectiveness analysis) OR cost-utility analysis) OR cost-benefit analysis) OR cost-minimization analysis
17 5
EMBASE 2018.03.19 #1 Peritoneal Carcinomatosis
#2 Hyperthermic Intraperitoneal Chemotherapy
#3 cost
28 1/ 4
一篇重複於 pubmed 搜尋
兩篇為同一 作者之不同 的研討會摘 要)
Cochrane 2018.03.19 #1 Peritoneal Carcinomatosis
#2 Hyperthermic Intraperitoneal Chemotherapy
#3 cost
2 1 (重複於 pubmed 搜尋)